President Donald Trump announced Friday that nine additional pharmaceutical companies joined its most-favored-nation pricing ...

President Trump announced nine more pharmaceutical companies have agreed to implement "most favored nation pricing".

President Donald Trump opens up about the 'Trump gold card,' reducing the federal workforce, and lowering the cost of ...

Millions of Medicare Part D enrollees will see substantial out-of-pocket savings as negotiated drug prices take effect in ...

Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead, GSK, Merck, Novartis and Sanofi have agreed to drug pricing deals.

Starting in 2026, people who are insured through Medicare will pay no more than $2,100 out of pocket on prescription drugs over the year. That cap may be much lower than $2,100 due to a quirk in ...

Friday’s announcement is the latest in a series of events in which Trump has boasted of securing cooperation from drug makers ...

The White House announced new agreements with nine pharmaceutical companies to lower prescription drug prices Friday. (Scripps News) ...

Nine drug manufacturers will offer their drugs to Medicaid recipients at most-favored-nation discounts in exchange for tariff ...

The commonwealth claims that pharmacy benefit managers and drug manufacturers are in cahoots to inflate insulin prices for ...

The agreement will lower the cost of certain drugs for asthma, some cancers, HIV and Type 2 diabetes, among other conditions.

President Donald Trump announced nine of the largest drugmakers in the U.S. and Europe agreed to voluntarily sell their ...